Evidence level: B
外气疗效的”个体依赖性”不是不可知的黑箱——它可能由可测量的治疗师生理状态与治疗剂量共同构成,而这两者恰恰都有对应的现代测量工具。
正文
上一篇我们讲过:外气(External Qigong)最扎眼的证据特征,是疗效高度依赖”谁在发功”。同一项膝骨关节炎盲法随机对照试验里,两位气功师的结果截然不同——治疗师 2 的患者疼痛改善(-25.7 vs 假治疗 -13.1,p<0.01)与功能均显著优于对照,治疗师 1 的患者则与对照组无差异(PMID 18654733)。面对这种”个体依赖性”,一个自然的问题是:那个让疗效出现差别的”治疗师特质”,到底是玄学,还是可以测量、可以建模、甚至可以训练的变量? 本文把散落在文献里的线索拼起来,看看这条路能走多远。
线索一:治疗师确实存在可测的生理”做功状态”。 对生物场治疗师的研究做过系统梳理:67 项研究中 22 项符合纳入标准,最常测量的指标是脑电(EEG)和心率变异性(HRV),结果发现部分疗法(Reconnective Healing、Bruyere、夏威夷疗愈)的治疗师在进入治疗状态时 HRV 呈”唤起”模式,而另一些(Reiki、Therapeutic Touch)没有可测变化(PMID 24767262)。另一项更新的综述(44 项研究)结论更直白:治疗师在”发功”时确实会进入一种生理可区分的状态,EEG/HRV 都能测到与基线不同的信号,只是不同传统之间不一致(PMID 38300148)。换句话说,”发功状态”至少有 HRV 和 EEG 两个候选测量通道——问题只是缺统一的测量协议。
线索二:剂量-反应关系已被部分观察到。 实验室层面,加州太平洋医学中心做过严格双盲的剂量实验:让一位气功师隔着 0.25 米对培养的癌细胞发功,比较 1、2、5 次治疗(每次 5 分钟)的效应,结果呈现”治疗次数越多、细胞活性下降越多”的剂量趋势,可惜未达统计显著且复制失败(PMID 22732075)。人群层面,日本一项 44587 人的大样本横断面研究显示:单次生物场治疗后症状改善率(疼痛 69.7%、心悸/头晕 67.5%、焦虑/抑郁 71.2%)与治疗时长(≥30 分钟更优)和治疗地点显著相关(PMID 22875592)。两项研究叠加:剂量确实与效应挂钩,只是剂量轴的形状还不清楚。
线索三:经验梯度是”治疗师特质”最接近的可测代理。 不同修炼年限/经验水平的气功师,其自主神经与脑功能基线存在系统性差异:有研究对比资深法轮功练习者与新手,发现练习者左半球情绪加工网络对积极情绪线索的易感性下降(η²=0.34)、复杂半球间转移任务显著更优(η²=0.21),且冲突解决能力与高频 HRV 正相关(r²=0.40)(PMID 31811982)。这提示”修为”在注意网络和自主神经层面留下了可量化痕迹。而疗效侧,非接触生物场疗法的系统综述把现有 RCT 评为”质量低、样本小、疗效指标异质”,并明确点名:纳入的 RCT 中只有少数按治疗师分层分析(PMID 25181286)。一边是”有希望但弱”,一边是”经验差异可测”,缺的正是把它们连起来的正式建模。
把三条线索拼起来,就得到”治疗师效应可测化”的完整蓝图——多治疗师特质量表 + 发功状态生理标志 + 疗效结局的三层剂量-反应建模:治疗师特质(修为年限、自评能力、标准化量表)与发功状态(HRV 频域、EEG 相干、呼吸相干)构成”剂量”输入,疗效结局(疼痛/焦虑/症状评分)构成”反应”输出,用多层模型显式建模治疗师效应。这条路的最大价值在于把争议从”外气有没有效”转移到”外气的有效成分能不能被刻画”——即使最终证明”剂量-反应”不存在,那也是对文献里互相矛盾结果的负责任解释。
当然,障碍同样真实。其一,现有研究几乎都没系统报告治疗师的特征数据,治疗师间异质性很少被显式建模。其二,生理标志跨传统不一致,统一协议缺失。其三,也是最根本的:如果疗效真的由”人”承载,那么任何单个治疗师的小样本研究都不可外推——这正是当前证据库碎片化的根源。
证据与局限
已验证: 治疗师间差异真实存在(PMID 18654733 两位治疗师同协议结果相反);治疗师”发功状态”存在可测生理改变(EEG/HRV,PMID 24767262、PMID 38300148);治疗次数/时长与效应的关联有初步数据(PMID 22732075 剂量趋势、PMID 22875592 时长效应)。
部分验证: 经验/修炼年限在自主神经与脑网络上留下可量化差异(PMID 31811982),但尚未与疗效结局直接挂钩;非接触生物场疗法的疗效证据总体”有希望但薄弱”(PMID 25181286)。
待验证: 治疗师特质(量表+生理标志)能否预测疗效的单次结局;剂量-反应曲线的形状与阈值;同一治疗师跨场合的效应稳定性(”修为”在多大程度上等于”疗效”)。
相关阅读
证据等级: B(科学类比/间接证据:治疗师效应与生理标志各有独立支撑,但”特质→疗效”的完整因果链尚无直接检验)
参考文献: PMID 18654733, PMID 24767262, PMID 38300148, PMID 22732075, PMID 22875592, PMID 31811982, PMID 25181286
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
Healer Effect of External Qi: From \”Who Is Channeling\” to Measurable Dose-Response
Evidence level: B
The “individual dependence” of external qi efficacy is not an unknowable black box—it may be constituted by the measurable physiological state of the therapist and the treatment dose, both of which have corresponding modern measurement tools.
Main Text
In the previous article, we noted that the most striking evidentiary feature of external qi (External Qigong) is its high dependence on “who performs the practice.” In a single blinding randomized controlled trial for knee osteoarthritis, two qigong masters produced divergent results: patients treated by Master 2 showed significantly better pain reduction (-25.7 vs. -13.1 for sham treatment, p<0.01) and functional improvement compared to the control group, whereas patients treated by Master 1 showed no difference from controls (PMID 18654733). Confronting this “individual dependence,” a natural question arises: Is the “therapist characteristic” responsible for these efficacy differences esoteric, or is it a measurable, modelable, and potentially trainable variable? This article synthesizes scattered clues from the literature to assess how far this path can be taken.
Clue 1: Therapists exhibit measurable physiological “working states.” A systematic review of research on biofield therapists identified 22 studies meeting inclusion criteria out of 67, with the most frequently measured indicators being electroencephalography (EEG) and heart rate variability (HRV). Results indicated that for certain therapies (Reconnective Healing, Bruyere, Hawaiian Healing), therapists entered an “arousal” mode during treatment states, whereas others (Reiki, Therapeutic Touch) showed no measurable changes (PMID 24767262). A more recent systematic review (44 studies) concluded more directly: therapists do indeed enter a physiologically distinguishable state during “practice,” with EEG and HRV detecting signals distinct from baseline, though consistency varies across traditions (PMID 38300148). In other words, the “practice state” has at least two candidate measurement channels: HRV and EEG; the issue remains a lack of unified measurement protocols.
Clue 2: Dose-response relationships have been partially observed. At the laboratory level, the Pacific Center for Integrative Medicine in California conducted a rigorous double-blind dose experiment: one qigong master performed practice on cultured cancer cells across a distance of 0.25 meters, comparing effects after 1, 2, and 5 sessions (5 minutes each). Results showed a dose trend where “more treatment sessions correlated with greater cell viability reduction,” though this did not reach statistical significance and replication failed (PMID 22732075). At the population level, a large-scale Japanese cross-sectional study of 44,587 individuals found that symptom improvement rates after a single biofield treatment (pain 69.7%, palpitations/dizziness 67.5%, anxiety/depression 71.2%) were significantly associated with treatment duration (≥30 minutes being superior) and treatment location (PMID 22875592). Combining these two studies: dose is indeed linked to effect, though the shape of the dose axis remains unclear.
Clue 3: Experience gradients are the most proximate measurable proxies for “therapist characteristics.” Qigong masters with varying years of cultivation or experience levels exhibit systematic differences in baseline autonomic and brain functions. One study comparing seasoned Falun Gong practitioners with novices found that practitioners showed reduced susceptibility in the left-hemisphere emotional processing network to positive emotional cues ($\eta^2=0.34$), significantly better performance on complex inter-hemispheric transfer tasks ($\eta^2=0.21$), and a positive correlation between conflict resolution ability and high-frequency HRV ($r^2=0.40$) (PMID 31811982). This suggests that “cultivation” leaves quantifiable traces at the levels of attention networks and autonomic function. On the efficacy side, a systematic review of non-contact biofield therapies rated existing RCTs as “low quality, small sample sizes, heterogeneous efficacy metrics,” explicitly noting that only a minority of included RCTs performed subgroup analyses by therapist (PMID 25181286). One side offers “promising but weak” data; the other shows “experience differences are measurable.” What is missing is a formal model connecting them.
Synthesizing these three clues yields a complete blueprint for “measurable therapist effects”—a three-layer dose-response modeling framework combining multi-therapist characteristic scales, physiological markers of practice states, and efficacy outcomes: Therapist characteristics (years of cultivation, self-rated ability, standardized scales) and practice states (HRV frequency domains, EEG coherence, respiratory coherence) constitute the “dose” input; efficacy outcomes (pain/anxiety/symptom scores) constitute the “response” output; and multi-level models explicitly model the therapist effect. The greatest value of this approach lies in shifting the debate from “whether external qi is effective” to “whether the active components of external qi can be characterized”—even if final proof shows no “dose-response” exists, it would still constitute a responsible explanation for contradictory results in the literature.
Of course, obstacles are equally real. First, existing studies rarely report therapist characteristic data systematically, and inter-therapist heterogeneity is seldom explicitly modeled. Second, physiological markers are inconsistent across traditions, with no unified protocol. Third, and most fundamentally: if efficacy truly is carried by the “person,” then any single-therapist small-sample study cannot be extrapolated—this is precisely the root cause of current fragmentation in the evidence base.
Evidence and Limitations
Verified: Inter-therapist differences are real (PMID 18654733 shows opposite results for two therapists under identical protocols); measurable physiological alterations exist in the “practice state” (EEG/HRV, PMID 24767262, PMID 38300148); associations between treatment frequency/duration and effects have preliminary data (PMID 22732075 shows dose trend, PMID 22875592 shows duration effect).
Partially Verified: Experience/cultivation years leave quantifiable differences in autonomic and brain networks (PMID 31811982), but these have not yet been directly linked to efficacy outcomes; evidence for non-contact biofield therapy efficacy is generally “promising but weak” (PMID 25181286).
To Be Verified: Whether therapist characteristics (scales + physiological markers) can predict single-session efficacy outcomes; the shape and threshold of the dose-response curve; cross-context stability of effects by the same therapist (to what extent does “cultivation” equal “efficacy”).
Related Reading
- Scientific Validation of External Qi Efficacy: Individual Dependence and Reproducibility
- Regulation of Others’ Physiological Processes by External Qi: Mechanism Studies
- Blinded Multi-Level Modeling for Objective Measurement of Therapist Characteristics
- Quantitative Associations Between Qigong Cultivation Levels and Neuro-Oscillation Features
- Research Pool P1: Resonant Consciousness Field
Evidence Level: B (Scientific Analogy/Indirect Evidence: Therapist effects and physiological markers each have independent support, but the complete causal chain from “characteristics to efficacy” lacks direct testing)
References: PMID 18654733, PMID 24767262, PMID 38300148, PMID 22732075, PMID 22875592, PMID 31811982, PMID 25181286
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.
Leave a Reply